Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03247829 · ClinicalTrials.gov registry record
Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 101
- Enrollment target
NCT03247829 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 101 participants.
The verdict
NCT03247829 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
This observational post market study is intended to characterize hemodynamic-guided management of patients with an existing left ventricular assist device (LVAD) to protocol specified target ranges and its impact on functional status, quality of life, and readmissions
Interventions
- DEVICE Hemodynamic management using CardioMEMS HF System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2017-08-24 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03247829
The ClinicalTrials.gov registry entry for NCT03247829 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hemodynamic management using CardioMEMS HF System is the first listed.
NCT03247829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03247829 about?
NCT03247829 is a clinical study titled "Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™". This observational post market study is intended to characterize hemodynamic-guided management of patients with an existing left ventricular assist device (LVAD) to protocol specified target ranges and its impact on functional status, quality of life, and readmissions
What is the current status of trial NCT03247829?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2017-08-24. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03247829?
The interventions under investigation include: Hemodynamic management using CardioMEMS HF System (DEVICE).
Who is sponsoring clinical trial NCT03247829?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.